Canada

Health Canada approves UPLIZNA® (inebilizumab injection) for the treatment of neuromyelitis optica spectrum disorder (NMOSD)

Horizon Therapeutics plc, now a component of Amgen, announced that on December 15, 2023, Health Canada approved UPLIZNA® (inebilizumab injection) as monotherapy for the treatment of adult patients with NMOSD who are AQP4-IgG. This rare autoimmune disease is caused by inflammation of the central nervous system, which causes severe and recurrent seizures that can lead to permanent disability, such as vision loss and paralysis. 1 An estimated 1,000 other people in Canada are living with the disease. 2,3,4

Health Canada approves UPLIZNA® (inebilizumab injection) for the treatment of neuromyelitis optica spectrum disorder (NMOSD) Read More »

Fight on Inflation, Flattens Canada’s Economy

OTTAWA, Jan. 16, 2024 (GLOBE NEWSWIRE) — Canada remains in an economic bind as peak interest rates weigh on the purchasing power of businesses and consumers, according to a new study from the Conference Board of Canada. The country’s genuine GDP is expected to grow by just 0. 6% in 2024. “Inflation has moderated and is expected to continue to moderate, but we will see drastic rate relief from the Bank of Canada before the middle of the year,” according to Ted Mallett. Array, director of economic forecasting at The Confere

Fight on Inflation, Flattens Canada’s Economy Read More »

Canada Life Announces Jeff Macoun’s Retirement

Canada Life today announced the upcoming retirement of Jeff Macoun, President and Chief Operating Officer of its Canadian operations, and the upcoming appointment of Fabrice Morin to the role. After a career of more than 40 years with the company, Jeff will transition into the role. In his new role, Fabrice will assume executive duties for Canada Life’s Canadian operations and join the Executive Committee of Great-West Lifeco Inc. Both adjustments will take effect.

Canada Life Announces Jeff Macoun’s Retirement Read More »